Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies (BSEM)
:BSEM
BSEM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.77 - $28.26
Previous CloseN/A
Volume47.30K
Average Volume (3M)73.14K
Market Cap
$203.41M
Enterprise Value$199.88M
Total Cash (Recent Filing)$140.74K
Total Debt (Recent Filing)$5.11M
Price to Earnings (P/E)19.5
Beta1.63
Next Earnings
Apr 07, 2025EPS Estimate
0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.64
Shares Outstanding16,338,436
10 Day Avg. Volume65,182
30 Day Avg. Volume73,145
Standard Deviation0.30
R-Squared0.07
Alpha0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)75.19
Price to Cash Flow (P/CF)2642.60
P/FCF Ratio355.10
Enterprise Value/Market Cap0.98
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit12.96
Enterprise Value/Ebitda9.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BioStem Technologies News
PremiumCompany Announcements
BioStem Technologies Achieves Record Revenue Growth in Q3 2024
PremiumPre-Earnings
Is BSEM a Buy, Before Earnings?
---
BSEM FAQ
What was BioStem Technologies ’s price range in the past 12 months?
BioStem Technologies lowest stock price was $6.77 and its highest was $28.26 in the past 12 months.
What is BioStem Technologies ’s market cap?
BioStem Technologies ’s market cap is $203.41M.
When is BioStem Technologies ’s upcoming earnings report date?
BioStem Technologies ’s upcoming earnings report date is Apr 07, 2025 which is in 34 days.
How were BioStem Technologies ’s earnings last quarter?
BioStem Technologies released its earnings results on Nov 12, 2024. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.36 by -$0.04.
Is BioStem Technologies overvalued?
According to Wall Street analysts BioStem Technologies ’s price is currently Overvalued.
Does BioStem Technologies pay dividends?
BioStem Technologies does not currently pay dividends.
What is BioStem Technologies ’s EPS estimate?
BioStem Technologies ’s EPS estimate is 0.37.
How many shares outstanding does BioStem Technologies have?
BioStem Technologies has 16,338,436 shares outstanding.
What happened to BioStem Technologies ’s price movement after its last earnings report?
BioStem Technologies reported an EPS of $0.32 in its last earnings report, missing expectations of $0.36. Following the earnings report the stock price went up 1.052%.
Which hedge fund is a major shareholder of BioStem Technologies ?
Currently, no hedge funds are holding shares in BSEM
---
BioStem Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BSEM Sentiment 70%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.12%
12-Months-Change
Fundamentals
Return on Equity
153.40%
Trailing 12-Months
Asset Growth
1692.34%
Trailing 12-Months
Company Description
BioStem Technologies
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on July 7, 2006 and is headquartered in Oakland Park, FL.
---
BSEM Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance with record-breaking revenue and strategic advancements. Despite increased operating expenses and ongoing challenges with Medicare reimbursement policies, the overall outlook remains positive with significant milestones achieved and a promising future trajectory.Read More>---
Technical Analysis
---